ERBB2 and breast carcinoma: The nano-HER2-E3-C-488 co-associated with mScarlet-K3 was tested by flow-cytometry on two breast cancer cells lines, HER2-positive HCC1954, HER2-negative MDA-MB-231 [21] and on HER2-silenced HCC1954 cells using small-interfering oligonucleotides (Figure 3A,B and Figure S4A,B).